0001097149false00010971492025-07-022025-07-02
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 2, 2025
ALIGN TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Delaware |
|
000-32259 |
|
94-3267295 |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
410 North Scottsdale Road, Suite 1300, Tempe, Arizona 85288
(Address of principal executive offices) (Zip Code)
(602) 742-2000
(Registrant’s telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
|
|
|
|
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
| Common stock, $0.0001 par value |
ALGN |
The NASDAQ Stock Market LLC |
|
|
(NASDAQ Global Select Market) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
The Board of Directors (the “Board”) of Align Technology, Inc. (the “Company”) appointed Britt Vitalone, 56, to the Board, effective July 2, 2025. In connection with this appointment, the Board increased the size of the Board from ten to eleven directors. The Company expects Mr. Vitalone to stand for election at the next annual meeting of stockholders, which is expected to be held in May 2026. The Board also appointed Mr. Vitalone to serve on the Audit Committee, effective July 2, 2025.
Mr. Vitalone will participate in the compensation program for non-employee directors as described under the heading “Director Compensation” in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission (the “SEC”) on April 8, 2025, except that the annual retainer and equity grant will be prorated to reflect service from the date of appointment until the Company’s annual meeting of stockholders in 2026.
Mr. Vitalone has also entered into a director indemnification agreement with the Company, the form of which is disclosed as Exhibit 10.21 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 28, 2025, and which is incorporated by reference herein.
There is no arrangement or understanding between Mr. Vitalone and any other person pursuant to which he was selected as a director. Mr. Vitalone has no direct or indirect material interest in any existing or currently proposed transaction that would require disclosure under Item 404(a) of Regulation S-K.
A copy of the press release announcing Mr. Vitalone’s appointment to the Board is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
|
|
|
|
|
| Exhibit No. |
Description |
|
|
| 104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
ALIGN TECHNOLOGY, INC. |
|
|
|
|
By: |
/s/ John Morici |
|
|
John Morici
Chief Financial Officer and Executive Vice President, Global Finance |
Date: July 2, 2025
EX-99.1
2
alignannouncesbrittvitalon.htm
EX-99.1
Document
Exhibit 99.1
|
|
|
|
|
|
| Align Technology |
Zeno Group |
| Madelyn Valente |
Sarah Karlson |
| (909) 833-5839 |
(828) 551-4201 |
| mvalente@aligntech.com |
sarah.karlson@zenogroup.com |
BRITT VITALONE JOINS ALIGN TECHNOLOGY BOARD OF DIRECTORS
TEMPE, Ariz., SAN JOSE, Calif., DALLAS, July 2, 2025 - Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Britt Vitalone, Executive Vice President and Chief Financial Officer (“CFO”), McKesson Corporation, to Align’s Board of Directors along with its Audit Committee.
“I am pleased to welcome Britt to Align’s board of directors,” said Joe Hogan, president and CEO of Align Technology. “His deep expertise as a business and financial leader in the healthcare industry will be an incredible asset to Align as we continue to drive growth and innovation globally by delivering digital solutions across the Align™ Digital Platform to help more doctors increase practice efficiency and deliver the best possible Invisalign® treatment outcomes for their patients.”
Britt Vitalone (photo)
Mr. Vitalone currently serves as Executive Vice President and Chief Financial Officer for McKesson Corporation and is a member of the executive operating team. He is responsible for ensuring that the company’s strategy creates and aligns to shareholder value; communicating the company’s strategies and performance to investors; and implementing a capital structure, financial processes and controls to support the company’s growth and return on investment goals. As CFO, Mr. Vitalone oversees the accounting, financial planning and analysis, treasury, real estate, investor relations, internal audit, merger & acquisition and tax functions at McKesson. In addition to leading McKesson’s Enterprise Finance organization, he also
Align Technology, Inc. 410 N. Scottsdale Road, Suite 1300, Tempe, AZ 85281
Tel: (602) 742-2000
WWW.ALIGNTECH.COM
oversees the company’s global procurement and sourcing, corporate security, and McKesson Technology (“MT”) organizations. Mr. Vitalone joined McKesson in 2006 and has served as a financial executive leader in several major businesses within the company, including senior vice president & CFO of McKesson’s U.S. Pharmaceutical and Specialty Health unit. Additionally, he was senior vice president of Corporate Finance and Merger & Acquisition Finance, and senior vice president & CFO of McKesson’s Medical-Surgical unit. Outside of McKesson, Mr. Vitalone is a member of the CNBC Global CFO Council. Mr. Vitalone holds a Bachelor of Science in Accounting from St. John Fisher University.
Mr. Vitalone will be included in Align’s slate of director nominees in the proxy statement for Align’s 2026 Annual Meeting of Shareholders. With the addition of Mr. Vitalone, Align increased the size of its board to 11 directors, six of whom have been appointed since 2017.
About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.
For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.
Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.
エドガーで原本を確認する
